Life Scientist > Health & Medical

Sniffing out Alzheimer's early

24 August, 2017 by Adam Florance

Canadian researchers have found that a simple smell test may help in diagnosing those at risk of developing Alzheimer's disease.


'Stiffer' blood vessels may increase risk of heart attack

22 August, 2017

Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease.


Inadequate T-cell development linked to autoimmune diseases

18 August, 2017 by Adam Florance

Researchers have determined that mutations in the gene encoding a particular enzyme may help in the development of better treatments for a wide range of autoimmune diseases.


Tumour blood supply stopped in its tracks by dextran-catechin

10 August, 2017 by Adam Florance

An international study, led by researchers from the Children's Cancer Institute and University of New South Wales, has uncovered a new way of dealing with neuroblastoma, a form of cancer that typically affects infants as young as one or two years of age.


LBT to trial diabetic foot ulcer prototype

09 August, 2017

LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial.


Targeting the Achilles' heel of breast cancer

04 August, 2017 by Adam Florance

Researchers have found that by combining traditional treatments with a new class of anticancer agents they can target the 'Achilles' heel' of HER2-positive breast cancers, in the first significant improvement in this area in over 30 years.


Blocking the enzyme that helps tumours grow

03 August, 2017

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to scientists from the University of Southampton.


HaemaLogiX signs research agreement with local health institutions

27 July, 2017

HaemaLogiX, an Australian immuno-oncology company, has signed an agreement with local health and research institutions for commercialisation rights to an immuno-oncology agent designed to specifically target malignant cancer cells present in the bone marrow of multiple myeloma patients.


Link between high brain iron levels and Alzheimer's

25 July, 2017

New research has shown an association between higher levels of brain iron, the presence of Alzheimer's protein amyloid, and poorer memory and language skills.


Prana partners with Takeda to study lead drug

19 July, 2017

Prana Biotechnology has formed a research collaboration with Takeda Pharmaceuticals to study the ability of Prana's investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.


Oventus receives FDA clearance for O2Vent W

14 July, 2017

Australian medical device company Oventus Medical has received FDA 510k clearance for its O2Vent W device.


UQ researchers identify protein to control breast cancer progression

13 July, 2017

University of Queensland researchers have discovered that switching off a protein produced in breast cancer cells can stop cancer progression.


RMIT research points to treatment breakthrough for viruses

13 July, 2017 by Adam Florance

An international collaboration headed by RMIT University researchers has discovered a novel new way of treating viral diseases including HIV, dengue, rhinovirus, and influenza, the last of which infects five million people annually with a death rate as high as 10%.


Optimistic cancer researchers overestimate reproducibility of preclinical studies

05 July, 2017

Cancer scientists have been found to overestimate the extent to which high-profile preclinical studies can be successfully replicated, in a study that follows numerous reports exploring biomedicine's so-called reproducibility crisis.


Monash IVF and RHS begin non-invasive PGS trial

29 June, 2017

Australian listed companies Monash IVF and RHS (Reproductive Health Science) have partnered to develop an accurate way to test for chromosome number in embryos without biopsy.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd